Evidence map›Paper›PMID 30999606›Full record

ArticleMolecules (Basel, Switzerland)2019

Lipophilicity as a Central Component of Drug-Like Properties of Chalchones and Flavonoid Derivatives.

Teodora Constantinescu, Claudiu Nicolae Lungu, Ildiko Lung

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Chemical Profiling and Cheminformatic Insights intoMolecules (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Identification ofMetabolites · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Synthesis and Development ofAntibiotics (Basel, Switzerland) · 2023
    Article
  17. Article
  18. Two Important Anticancer Mechanisms of Natural and Synthetic Chalcones.International journal of molecular sciences · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Teodora ConstantinescuDepartment of Chemistry, Faculty of Pharmacy, Iuliu Hatieganu University, 400012 Cluj-Napoca, Romania. teo_farma@yahoo.com.
Claudiu Nicolae LunguDepartment of Chemistry, Faculty of Chemistry and Chemical Engineering, Babes-Bolyai University, 400028 Cluj-Napoca, Romania. lunguclaudiu5555@gmail.com.ORCID 0000-0002-5416-3142
Ildiko LungNational Institute for Research & Development of Isotopic and Molecular Technologies 67-103 Donath street, 400293 Cluj-Napoca, Romania. ildiko.lung@itim-cj.ro.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipophilcity is an important physico-chemical parameter that influences membrane transport and binding ability to action. Migration distance following complete elution of compounds was used to calculate different lipophilicity-related parameters. The aim of this study is to show that lipophilicity is a central component of thiazole chalcones and flavonoid derivatives regarding their drug-like properties. Experimental and computational methods were used. This study considers 44 previously synthesized compounds (thiazole chalcones, flavanones, flavones, 3-hydroxyflavones, and their acetylated derivatives). The concerned compounds have shown antitumoral hallmarks and antibacterial activity in vitro. The experimental method used to determine compounds' lipophilicity was the reverse-phase thin layer chromatography (RP-TLC). Lipophilicity related parameters-isocratic retention factor (R

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsChalconesFlavonoidsChromatography, Reverse-PhaseChromatography, Thin LayerHydrophobic and Hydrophilic InteractionsAnti-Bacterial AgentsAntineoplastic AgentsChalconesFlavonoidschalconeschromatographydrug designlipophilicityQSARretention factor

Identifiers

PMID30999606
PMCPMC6515054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.